Hyperlipidemias: Clinical Trials

23 trials for Hyperlipidemias, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

23 terminated. 23 Phase 2, 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 223Terminated 23
Phase 13Terminated 3

Follow Hyperlipidemias: new trials by email Literature Review of Hyperlipidemias trials Research Report on Hyperlipidemias

Trials (filtered) newest first · largest first

All 23 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of ARO-ANG3 in Participants With Homozygous Familial Hypercholesterolemia (HOFH)
ARO-ANG 3 Injection - Homozygous Familial Hypercholesterolemia
Phase 2TerminatedArrowhead Pharmaceuticals182022-04-222026-06-12
Efficacy and Safety of Evinacumab in Adult Patients With Severe Hypertriglyceridemia for the Prevention of Recurrent Acute Pancreatitis
evinacumab, Placebo - Hypertriglyceridemia
Phase 2TerminatedRegeneron Pharmaceuticals212021-07-122024-05-22
Assess Efficacy and Safety of Epeleuton in Patients With Hypertriglyceridemia and Type 2 Diabetes
DS102, Placebo - Hypertriglyceridemia, Type 2 Diabetes
Phase 2TerminatedAfimmune2332020-10-132023-06-12
A Gene Therapy Study for Homozygous Familial Hypercholesterolemia (HoFH)
AAV directed hLDLR gene therapy - Homozygous Familial Hypercholesterolemia (HoFH)
Phase 1 / Phase 2TerminatedREGENXBIO Inc.92016-03-012023-07-13
Phase 2 Study of Orlistat and SLx-4090 for the Treatment of Type 1 Hyperlipoproteinemia
SLx-4090 placebo, Orlistat Placebo, Orlistat - Type 1 Hyperlipoproteinemia
Phase 2TerminatedUniversity of Texas Southwestern Medical Center52015-11-012021-08-19
Study of Adrenalectomy Versus Observation for Subclinical Hypercortisolism
Adrenalectomy, Observation - Subclinical Hypercortisolism, Cushing Syndrome
Phase 2TerminatedNational Cancer Institute (NCI)42013-11-272018-06-14
Supplementation With Omega-3: Mechanism of Action
DHA-enriched, EPA-enriched - Hypertriglyceridemia
Phase 2TerminatedJohns Hopkins University132013-04-012017-03-01
Efficacy of LCQ908 on Cardiovascular Risk
pradigastat (LCQ908), Placebo - Coronary Artery Disease, Hypertriglyceridemia
Phase 2TerminatedNovartis Pharmaceuticals412011-12-012016-04-14
Pharmacodynamic Clinical Trial of Cardiovascular Polypill on LDL Cholesterol
Cardiovascular fixed dose combination pill (acetylsalicylic acid, simvastatin and ramipril), Simvastatin, ramipril, acetylsalicylic acid - Elevated LDL Cholesterol
Phase 2TerminatedFerrer Internacional S.A.1072010-10-012013-04-24
A Pharmacodynamic Study to Evaluate the Effect of a Fixed Dose Combination Pill on Low Density Lipoprotein (LDL) Cholesterol
Cardiovascular fixed dose combination pill (acetylsalicylic acid, simvastatin and ramipril),, Simvastatin - Elevated LDL Cholesterol
Phase 2TerminatedFerrer Internacional S.A.362009-09-012012-08-31
IMPAACT P1063: Safety and Effectiveness of Atorvastatin in HIV Infected Children and Adolescents With Hyperlipidemia
Atorvastatin - HIV Infections, Hyperlipidemia
Phase 1 / Phase 2TerminatedInternational Maternal Pediatric Adolescent AIDS Clinical Trials Group282009-08-012016-04-06
Effect of Omega-3 Fatty Acid Supplementation on Hypertriglyceridemia in HIV-infected Children
Omega Pure followed by placebo, Placebo followed by Omega Pure - Hypertriglyceridemia
Phase 2TerminatedThe Hospital for Sick Children132008-06-012014-06-12
Trial of Lovaza in Adolescents With Mild to Moderately Elevated Triglycerides
Lovaza, Placebo - Hypertriglyceridemia
Phase 2TerminatedBoston Children's Hospital252008-04-012013-05-29
Efficacy of Lapaquistat Acetate in Subjects With Hypercholesterolemia
Lapaquistat acetate, Placebo - Hypercholesterolemia
Phase 2TerminatedTakeda2242007-07-012012-05-24
A Randomized, Double-Blind, Placebo-Controlled Study to Examine the Effect of Betahistine on Plasma Lipids in Patients Treated With Simvastatin
Betahistine - Hypercholesterolemia
Phase 2TerminatedOBEcure Ltd.302007-05-012007-09-26
Statins to Reduce D-dimer Levels in Patients With Venous Thrombosis
atorvastatin, diet - Venous Thromboembolism, Hypercholesterolemia
Phase 2TerminatedUniversità degli Studi dell'Insubria102007-05-012011-08-19
MK0859 Dose-Ranging Study (0859-003)
MK0859 - Hypercholesterolemia, Mixed Hyperlipemia
Phase 2TerminatedMerck Sharp & Dohme LLC5002006-06-012015-03-02
Study of 3,5-Diiodothyropropionic Acid (DITPA) in Hypercholesterolemic Patients
3,5-Diiodothyropropionic acid (DITPA) therapy - Hypercholesterolemia
Phase 1 / Phase 2TerminatedJohns Hopkins University602006-04-012013-04-02
Implitapide in Patients With Hypertriglyceridemia (HTG) on Maximal, Concurrent Triglyceride-Lowering Therapy
implitapide - Hypertriglyceridemia
Phase 2TerminatedMedical Research Laboratories International502004-10-012005-06-24
Implitapide in Patients With Heterozygous Familial Hypercholesterolemia (HeFH) on Maximal Concurrent Lipid-Lowering Therapy
Implitapide - Familial Hypercholesterolemia
Phase 2TerminatedMedical Research Laboratories International1202003-10-012005-06-24

Showing 20 of 23. Sign in to see all of them.

Narrower conditions

Hypertriglyceridemia (8)  ·  Hypercholesterolemia (6)  ·  Hyperlipoproteinemia Type II (5)  ·  Homozygous Familial Hypercholesterolemia (3)  ·  Rare Diseases (2)  ·  Adrenal Gland Neoplasms (1)  ·  Adrenal incidentaloma (1)  ·  Atherosclerosis (1)  ·  Cardiovascular Diseases (1)  ·  Coronary Artery Disease (1)  ·  Cushing Syndrome (1)  ·  Diabetes Mellitus (1)  ·  Diabetes Mellitus, Type 2 (1)  ·  Dyslipidemias (1)

Broader conditions

Lipid Metabolism Disorders (23)  ·  Nutritional and Metabolic Diseases (23)  ·  Dyslipidemias (22)  ·  Metabolic Diseases (22)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (7)  ·  Hyperlipoproteinemias (7)  ·  Lipid Metabolism, Inborn Errors (7)  ·  Metabolism, Inborn Errors (7)  ·  Genetic Diseases, Inborn (6)  ·  Vascular Diseases (4)  ·  Cardiovascular Diseases (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Arterial Occlusive Diseases (2)  ·  Arteriosclerosis (2)

Interventions

Atorvastatin (3)  ·  implitapide (3)  ·  Aspirin (2)  ·  Blood Circulation (2)  ·  Ramipril (2)  ·  Simvastatin (2)  ·  1-((1-(3-acetoxy-2,2-dimethylpropyl)-7-chloro-5-(2,3-dimethoxyphenyl)-2-oxo-1,2,3,5-tetrahydro-4,1-benzoxazepin-3-yl)acetyl)piperidine-4-acetic acid (1)  ·  3,5-diiodothyropropionic acid (1)  ·  6-(4'-trifluoromethyl-6-methoxybiphenyl-2-ylcarboxamido)-1,2,3,4-tetrahydroisoquinoline-2-carboxylic acid phenyl ester (1)  ·  Acetylcholine (1)  ·  Adrenalectomy (1)  ·  Betahistine (1)  ·  Bradykinin (1)  ·  Corn Oil (1)  ·  Diet (1)

Sponsors

Medical Research Laboratories International (3)  ·  Ferrer Internacional S.A. (2)  ·  Johns Hopkins University (2)  ·  Afimmune (1)  ·  Arrowhead Pharmaceuticals (1)  ·  Boston Children's Hospital (1)  ·  Emory University (1)  ·  International Maternal Pediatric Adolescent AIDS Clinical Trials Group (1)  ·  Merck Sharp & Dohme LLC (1)  ·  National Cancer Institute (NCI) (1)  ·  National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1)  ·  Novartis Pharmaceuticals (1)  ·  OBEcure Ltd. (1)  ·  REGENXBIO Inc. (1)  ·  Regeneron Pharmaceuticals (1)

Countries

United States (18)  ·  Canada (5)  ·  Netherlands (5)  ·  Israel (3)  ·  Norway (3)  ·  Germany (2)  ·  Italy (2)  ·  Australia (1)  ·  Georgia (1)  ·  Latvia (1)  ·  South Africa (1)  ·  Spain (1)  ·  Switzerland (1)

Top investigators

Abhimanyu Garg, MD (1)  ·  Ann Melvin, MD (1)  ·  Annabelle Rodriguez, MD (1)  ·  Ari Bitnun, MD, MSc (1)  ·  Arshed A Quyyumi, MD (1)  ·  Davide Imberti (1)  ·  Dhananjay Vaidya (1)  ·  Dhaval T Patel, M.D. (1)  ·  Gualtiero Palareti (1)  ·  Jason Brophy, MD (1)  ·  Marilyn Crain, MD, MPH (1)  ·  Markus Weissbach, MD (1)

Results publications

PMID 21555712, PMID 21982664, PMID 24675657, PMID 24925526, PMID 25648989, PMID 25670366, PMID 25968622, PMID 38682459, PMID 41422812

NIH funding

P01HL059407 (1), R01HL079115 (1), R21DK053611 (1), U01AI068632 (1)